Search Results 391-400 of 16141 for SC
Saad A, Dietz AB, Herrmann SMS, Hickson LJ, Glockner JF, McKusick MA, Misra S, Bjarnason H, Armstrong AS, Gastineau DA, Lerman LO, Textor SC. Autologous ...
Treatment with any form of s.c. apomorphine within 7 days prior to the initial Screening Visit (SV1). Patients that stopped s.c. apomorphine for any reason ...
Find out more about the symptoms, diagnosis and treatment of this cancer of the lymphatic system.
Omalizumab injection is used to treat moderate to severe persistent allergic asthma. It is used when a patient's asthma has not been controlled sufficiently on ...
... SC, LoCastro E, Paudyal R, Wolansky IA, Shukla-Dave A, Schouten P, Gurney-Champion OJ, Jirik R, Macicek O, Bartos M, Vitous J, Das AB, Kim SG, Bokacheva L ...
The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed ...
... SC, Rule WG, Deufel CL, Foster MG. Development and Dosimetric Characterization of a Customizable Shield for Subtotal Skin Electron Beam Therapy. Adv Radiat ...
... S.C.. 2005. T. Leon Howard Pyelogram Conference - 1st place, Uterine adenosarcoma in a boy with PMDS69th Annual Southeast Section Meeting of the AUA ...
Learn about treatment of the serious bacterial infection commonly known as lockjaw and the vaccines that prevent it.
The purpose of this multinational, randomized, placebo-controlled, and double blind study is to evaluate the safety and efficacy of subcutaneous (SC) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.